Association of Body Mass Index with Risk of Cardiometabolic Disease, Multimorbidity and Mortality: a Multi-State Analysis Based on the Kailuan Cohort.

Xue Xia,Shuohua Chen,Xue Tian,Qin Xu,Yijun Zhang,Xiaoli Zhang,Jing Li,Penglian Wang,Shouling Wu,Anxin Wang
DOI: https://doi.org/10.1007/s12020-023-03570-w
2024-01-01
Endocrine
Abstract:To evaluate the association of body mass index (BMI) with risk of first cardiometabolic disease (FCMD), cardiometabolic multimorbidity (CMM) and death. 87,512 participants free of CMD were included from the Kailuan cohort, which was established during 2006–2007 and followed up until 2020. BMI was classified as underweight ( < 18.5 kg/m2), healthy weight (18.5–23.9 kg/m2), overweight (24.0–27.9 kg/m2), mildly obese (28.0–31.9 kg/m2), and severely obese ( ≥ 32.0 kg/m2). FCMD was defined as the first onset of diabetes, heart disease, or stroke, and CMM as the coexistence of at least two CMD. The hazard ratio (HR) and 95
What problem does this paper attempt to address?